Ecological Civilization Construction is the Fundamental Way to Develop Low-carbon Economy

AbstractThis article gives a brief account of the meaning, characteristics and origin of ecological civilization, an analysis of the positive impacts of ecological civilization construction on low-carbon economy, and proposes specific recommendations for constructing ecological civilization to develop low-carbon economy in China: compile “Planning Outline” and “Implementation Plan”, increase the publicity of education on ecological civilization concept, strengthen discussion on ecological civilization problems, establish government-enterprise cooperative platform, supporting systems of green technology and financial services to support ecological civilization construction, incorporate ecological civilization indicator into the performance evaluation of government departments, strengthen ecological civilization legislation.© 2011 Published by Elsevier Ltd. Selection and peer-review under responsibility of RIUD

Preparation of ZrB2-ZrC-SiC-ZrO2 nanopowders with in-situ grown homogeneously dispersed SiC nanowires

To explore the application of SiC nanowires (SiCnws) in ZrB2 based ceramic materials, a facile approach is reported to in situ synthesize homogeneously dispersed SiCnws in ZrB2-ZrC-SiC-ZrO2 nanopowders by pyrolyzing a B-Si-Zr containing sol precursor impregnated in polyurethane sponge. The sponge was used to provide porous skeletons for the growth of SiC nanowires and facilitate their uniform distribution in the powders. After heat-treatment of the precursor with a Si/Zr atomic ratio of 10 at 1500 °C for 2 h, ZrB2-ZrC-SiC-ZrO2 ceramic powders were obtained with an even and fine particle size of ~100 nm. The SiCnws were in a diameter of ~100 nm with a controllable length varying from tens to hundreds of microns by increasing the silicon content in the precursor. Moreover, the produced SiCnws were in high purity, and homogeneously dispersed in the hybrid nanopowders. The study can open up a feasible route to overcome the critical fabrication process in SiCnws reinforced ceramic matrix composites

Percutaneous Nephrolithotomy under Local Infiltration Anesthesia in Kneeling Prone Position for a Patient with Spinal Deformity

Urolithiasis, a common condition in patients with spinal deformity, poses a challenge to surgical procedures and anesthetic management. A 51-year-old Chinese male presented with bilateral complex renal calculi. He was also affected by severe kyphosis deformity and spinal stiffness due to ankylosing spondylitis. Dr. Li performed the percutaneous nephrolithotomy under local infiltration anesthesia with the patient in a kneeling prone position, achieving satisfactory stone clearance with no severe complications. We found this protocol safe and effective to manage kidney stones in patients with spinal deformity. Local infiltration anesthesia may benefit patients for whom epidural anesthesia and intubation anesthesia are difficult

Experimental study of organic Rankine cycle in the presence of non-condensable gases

Non-condensable gases (NCGs) are inevitable in organic Rankine cycle (ORC) system, and they have adverse impacts. A small-scale ORC test platform using scroll expander and R123 was constructed to investigate the NCGs effect. The expander backpressure (i.e. condenser outlet pressure) and electricity output were examined on different conditions of NCGs mass fraction (xNCG), hot side temperature (Th) and condensation temperature (Tc). Two new parameters, namely reduced coefficient of pressure ratio (RCOPR) and filling ratio of reservoir (FROR), were proposed to reveal the mechanism of ORC performance degradation in the presence of NCGs. The results show that the partial pressure of NCGs (PNCG) in reservoir at work differed from that at static state. Unlike R123, NCGs were blocked by the reservoir and had no access to the pump. The accumulation of NCGs led to unexpected expander backpressure, which could be 0.68 bar higher than the saturation pressure when Th = 140 °C, Tc = 50 °C and xNCG = 1.3%. PNCG generally increased as FROR rose. The FROR changed with Th, Tc and R123 mass flow rate. The relative increment in electricity output of the ORC with xNCG = 1.3% over that with xNCG = 12% was significant, and could reach 114% when Th = 100 °C and Tc = 50 °C

Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease

Circular RNAs (circRNAs) are genetic regulators that were earlier considered as “junk”. In contrast to linear RNAs, they have covalently linked ends with no polyadenylated tails. CircRNAs can act as RNA-binding proteins, sequestering agents, transcriptional regulators, as well as microRNA sponges. In addition, it is reported that some selected circRNAs are transformed into functional proteins. These RNA molecules always circularize through covalent bonds, and their presence has been demonstrated across species. They are usually abundant and stable as well as evolutionarily conserved in tissues (liver, lung, stomach), saliva, exosomes, and blood. Therefore, they have been proposed as the “next big thing” in molecular biomarkers for several diseases, particularly in cancer. Recently, circRNAs have been investigated in cardiovascular diseases (CVD) and reported to play important roles in heart failure, coronary artery disease, and myocardial infarction. Here, we review the recent literature and discuss the impact and the diagnostic and prognostic values of circRNAs in CVD

Distinct Roles of Bcl-2 and Bcl-Xl in the Apoptosis of Human Bone Marrow Mesenchymal Stem Cells during Differentiation

Background: Adult mesenchymal stem cells (MSCs) can be maintained over extended periods of time before activation and differentiation. Little is known about the programs that sustain the survival of these cells. Principal Findings: Undifferentiated adult human MSCs (hMSCs) did not undergo apoptosis in response to different cell death inducers. Conversely, the same inducers can readily induce apoptosis when hMSCs are engaged in the early stages of differentiation. The survival of undifferentiated cells is linked to the expression of Bcl-Xl and Bcl-2 in completely opposite ways. Bcl-Xl is expressed at similar levels in undifferentiated and differentiated hMSCs while Bcl-2 is expressed only in differentiated cells. In undifferentiated hMSCs, the down-regulation of Bcl-Xl is associated with an increased sensitivity to apoptosis while the ectopic expression of Bcl-2 induced apoptosis. This apoptosis is linked to the presence of cytoplasmic Nur 77 in undifferentiated hMSCs. Significance: In hMSCs, the expression of Bcl-2 depends on cellular differentiation and can be either pro- or anti-apoptotic. Bcl-Xl, on the other hand, exhibits an anti-apoptotic activity under all conditions

Matrix Metalloproteinase-8 Mediates the Unfavorable Systemic Impact of Local Irradiation on Pharmacokinetics of Anti-Cancer Drug 5-Fluorouracil

Concurrent chemoradiation with 5-fluorouracil (5-FU) is widely accepted for cancer treatment. However, the interactions between radiation and 5-FU remain unclear. Here, we evaluated the influence of local irradiation on the pharmacokinetics of 5-FU in rats. The single-fraction radiation was delivered to the whole pelvic fields of Sprague-Dawley rats after computerized tomography-based planning. 5-FU at 100 mg/kg was prescribed 24 hours after radiation. A high-performance liquid chromatography system was used to measure 5-FU in the blood. Matrix metalloproteinase-8 (MMP-8) inhibitor I was administered to examine whether or not RT modulation of 5-FU pharmacokinetic parameters could be blocked. Compared with sham-irradiated controls, whole pelvic irradiation reduced the area under the concentration versus time curve (AUC) of 5-FU in plasma and, in contrast, increased in bile with a radiation dose-dependent manner. Based on protein array analysis, the amount of plasma MMP-8 was increased by whole pelvic irradiation (2.8-fold by 0.5 Gy and 5.3-fold by 2 Gy) in comparison with controls. Pretreatment with MMP-8 inhibitor reversed the effect of irradiation on AUC of 5-FU in plasma. Our findings first indicate that local irradiation modulate the systemic pharmacokinetics of 5-FU through stimulating the release of MMP-8. The pharmacokinetics of 5-FU during concurrent chemoradiaiton therapy should be rechecked and the optimal 5-FU dose should be reevaluated, and adjusted if necessary, during CCRT

Personalized therapy for mycophenolate:Consensus report by the international association of therapeutic drug monitoring and clinical toxicology

When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy, fixed doses were recommended by the manufacturer. Awareness of the potential for a more personalized dosing has led to development of methods to estimate MPA area under the curve based on the measurement of drug concentrations in only a few samples. This approach is feasible in the clinical routine and has proven successful in terms of correlation with outcome. However, the search for superior correlates has continued, and numerous studies in search of biomarkers that could better predict the perfect dosage for the individual patient have been published. As it was considered timely for an updated and comprehensive presentation of consensus on the status for personalized treatment with MPA, this report was prepared following an initiative from members of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). Topics included are the criteria for analytics, methods to estimate exposure including pharmacometrics, the potential influence of pharmacogenetics, development of biomarkers, and the practical aspects of implementation of target concentration intervention. For selected topics with sufficient evidence, such as the application of limited sampling strategies for MPA area under the curve, graded recommendations on target ranges are presented. To provide a comprehensive review, this report also includes updates on the status of potential biomarkers including those which may be promising but with a low level of evidence. In view of the fact that there are very few new immunosuppressive drugs under development for the transplant field, it is likely that MPA will continue to be prescribed on a large scale in the upcoming years. Discontinuation of therapy due to adverse effects is relatively common, increasing the risk for late rejections, which may contribute to graft loss. Therefore, the continued search for innovative methods to better personalize MPA dosage is warranted.</p